Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
De D, Jamal ME, Aydemir E, Khera A
Since obesity is associated with an increased risk of cardiovascular disease, the ongoing SELECT study is investigating whether once-weekly semaglutide 2.4 mg will reduce the risk of having cardiovascular events in patients with overweight or obesity and with prior cardiovascular disease [61]
Abdullah Alenezi, Rashed Alhamdan, Torki Alotaibi, Ahmed Alqallaf, and Abdulmuhsen Alshammari have nothing to disclose
PubMed laboratory research record [PMID: 17644799] PubMed record related to this compound for laboratory literature review
US$ 27.40
US$ 24.90
US$ 28.38
US$ 21.12
US$ 22.64
US$ 20.90
US$ 24.18
